Liberal US Mayors Join European Pact to Counter National Governments

The Department of Health and Human Services continues to shield the public from basic information about the work of longtime anti-vaccine activist David Geier inside the agency. Weeks after Secretary Robert F. Kennedy Jr. pledged to Senate Democrats that he would share details of Geier contract, no documents have arrived and no explanation has been offered for the delay.

Senator Ben Ray Luján office reported that three weeks have passed since Kennedy promised the material within three days. A spokesperson for the New Mexico Democrat said the office has received nothing related to Geier employment or assignments. The silence has drawn fresh scrutiny from autism advocacy groups that have long described Geier as unqualified to shape federal health policy.

Geier and his late father Mark operated for years from a Maryland home where they promoted discredited theories linking vaccines to autism. Their organizations carried formal-sounding titles such as the Institute for Chronic Illness and the Genetic Centers of America, yet their published claims were repeatedly rejected by mainstream medical bodies. A 2003 review by the American Academy of Pediatrics faulted one of their studies for conceptual flaws, factual omissions and misstatements about thimerosal.

Mark Geier eventually lost his medical license after state boards found he had improperly treated autistic children with Lupron, a powerful drug used to chemically castrate sex offenders. The pair recommended the hormone suppressant despite lacking evidence it improved autism symptoms and despite known risks to developing bodies. David Geier carried on similar work after his father death, continuing to appear in legal and media settings as an expert on alleged vaccine injuries.

Kennedy appointment of Geier to an HHS position has alarmed public-health experts who note the department current responsibilities include vaccine safety monitoring and immunization programs. The agency has offered only vague assurances that Geier is providing research support, without naming projects or supervisors. Lawmakers on the Senate Finance Committee have pressed for the contract language and scope of work, yet the promised materials remain undelivered.

Advocates argue that placing an individual with Geier record in any policy-influencing role risks undermining years of evidence-based vaccine recommendations. They point to declining routine immunization rates in several states and rising outbreaks of measles and whooping cough as reasons for heightened caution. Without a clear description of Geier duties, they say, parents and physicians cannot assess whether federal guidance remains grounded in rigorous science.

HHS has not responded to repeated requests for clarification on Geier status. The prolonged lack of transparency comes as the agency faces broader questions about how it will handle vaccine-related communications under the current administration. For now, the public record shows only that Geier is on the payroll and that officials are unwilling to say what he is doing.